"Feasibility study on the identification of specific signal patterns with multifrequency ultrasound during carotid endarterectomy (CEA)"

"Feasibility study on the identification of specific signal patterns with multifrequency ultrasound during carotid endarterectomy (CEA)" - V-Clinic 0

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006022

Enrollment

Registered

2014-04-09

Start date

2014-04-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G45 I63

Interventions

Group 1: Patients with symptomatic high-grade internal carotid stenosis as a result of transient ischemic attack or ischemic stroke. Additional diagnostic routine to the monitoring device UltraEasy2:

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) patients with symptomatic high-grade internal carotid stenosis as a result of transient ischemic attack or ischemic stroke Thrombectomy (2) indication for surgical carotid eversion thrombectomy (3) Existence of informed consent

Exclusion criteria

Exclusion criteria: (1) The existence of intracerebral hemorrhage (2) Present broken skin within the scope of the medical device (redness, Neurodermatitis, etc.) and / or known allergy to ultrasound gel (3) Implementation of the carotid eversion thrombectomy later than 6 weeks after symptom onset (4) Severe heart failure, hemodynamically significant cardiac arrhythmias (5) contraindication to cerebral magnetic resonance imaging

Design outcomes

Primary

Measure	Time frame
Identification of specific signal pattern resulting from the reaction pattern of the monitoring device as part of the endarterectomy. Identification of clinical relevant events by specific reaction pattern of the monitoring device. 1 Examining the objectives to complete patient N = 10 2 Examining the objectives to complete patient N = 25 The clinical trial will end on 31.12.2014	—

Countries

Germany

Contacts

Public ContactWolf-Dirk Niesen

Neurologische Universitätsklinik Freiburg

wolf-dirk.niesen@uniklinik-freiburg.de0761 270 50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026